New Key Statistics Module, Z-Score and F-Score
NAS:ADAP Key Ratios
| Market Cap $ M | 268.34 |
| Enterprise Value $ M | 148.38 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 11.05 |
| Price/Sales | 12.50 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 18.00 |
| EPS (TTM) $ | -0.66 |
| Beneish M-Score | -2.62 |
| 10-y EBITDA Growth Rate % | -34.40 |
| 5-y EBITDA Growth Rate % | 4.40 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.78 |
| EV-to-EBITDA | -0.83 |
| PEG | -- |
| Shares Outstanding M | 255.56 |
| Net Margin (%) | -890.13 |
| Operating Margin % | -1,038.56 |
| Pre-tax Margin (%) | -883.39 |
| Quick Ratio | 2.81 |
| Current Ratio | 2.81 |
| ROA % (ttm) | -55.64 |
| ROE % (ttm) | -225.37 |
| ROIC % (ttm) | -161.46 |
| Dividend Yield % | -- |
| Altman Z-Score | -6.57 |
ADAP Number of Guru Trades
ADAP Volume of Guru Trades
Gurus Latest Trades with NAS:ADAP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ADAP is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Adaptimmune Therapeutics PLC Insider Transactions
No Available Data
News about NAS:ADAP
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers